SUNDARAM

Sundaram Multi Pap Share Price

₹2.77 0.00 (0.00%)

09 Dec, 2024 13:50

SIP TrendupStart SIP in SUNDARAM

Start SIP

Performance

  • Low
  • ₹3
  • High
  • ₹3
  • 52 Week Low
  • ₹2
  • 52 Week High
  • ₹4
  • Open Price₹3
  • Previous Close₹3
  • Volume629,150

Investment Returns

  • Over 1 Month -0.36%
  • Over 3 Month -5.78%
  • Over 6 Month + 0.73%
  • Over 1 Year -1.07%
SIP Lightning

Smart Investing Starts Here Start SIP with Sundaram Multi Pap for Steady Growth!

Invest Now

Sundaram Multi Pap Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -37.6
  • PEG Ratio
  • -0.9
  • Market Cap Cr
  • 131
  • P/B Ratio
  • 1.4
  • Average True Range
  • 0.11
  • EPS
  • 0
  • Dividend Yield
  • 0
  • MACD Signal
  • -0.03
  • RSI
  • 58.13
  • MFI
  • 59.12

Sundaram Multi Pap Financials

Sundaram Multi Pap Technicals

EMA & SMA

Current Price
₹2.77
0 (0%)
pointer
  • stock-down_img
  • Bullish Moving Average 11
  • stock-up_img
  • Bearish Moving Average 5
  • 20 Day
  • ₹2.67
  • 50 Day
  • ₹2.74
  • 100 Day
  • ₹2.84
  • 200 Day
  • ₹2.90

Resistance and Support

2.77 Pivot Speed
  • R3 2.96
  • R2 2.90
  • R1 2.83
  • S1 2.70
  • S2 2.64
  • S3 2.57

What's your outlook on Sundaram Multi Pap?

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Sundaram Multi Pap has an operating revenue of Rs. 128.88 Cr. on a trailing 12-month basis. An annual revenue growth of 7% is good, Pre-tax margin of -4% needs improvement, ROE of -5% is poor and needs improvement. The company has a reasonable debt to equity of 25%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its 200DMA and close to its 50DMA. It needs to take out the 200DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 45 which is a POOR score indicating inconsistency in earnings, a RS Rating of 24 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at C which is evident from recent supply seen, Group Rank of 46 indicates it belongs to a fair industry group of Paper & Paper Products and a Master Score of D is close to being the worst. Institutional holding has remained stable in the last reported quarter. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Sundaram Multi Pap Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-11-14 Quarterly Results
2024-08-12 Quarterly Results
2024-07-02 Others Inter-alia: 1. To consider and approve the date, time and venue of Extraordinary General Meeting. 2. To consider and approve the draft Notice of Extraordinary General Meeting.
2024-05-28 Audited Results
2024-03-27 Others To consider and approve the appointment of Statutory Auditor.

Sundaram Multi Pap F&O

Sundaram Multi Pap Shareholding Pattern

31.11%
0.03%
58.99%
9.87%

About Sundaram Multi Pap

  • NSE Symbol
  • SUNDARAM
  • BSE Symbol
  • 533166
  • Chairman & Managing Director
  • Mr. Amrut P Shah
  • ISIN
  • INE108E01023

Similar Stocks to Sundaram Multi Pap

Sundaram Multi Pap FAQs

Sundaram Multi Pap share price is ₹2 As on 09 December, 2024 | 13:36

The Market Cap of Sundaram Multi Pap is ₹131.3 Cr As on 09 December, 2024 | 13:36

The P/E ratio of Sundaram Multi Pap is -37.6 As on 09 December, 2024 | 13:36

The PB ratio of Sundaram Multi Pap is 1.4 As on 09 December, 2024 | 13:36

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23